Stay updated on CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial

Sign up to get notified when there's something new on the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.3 in the footer, replacing the previous Revision: v3.5.2. This indicates a minor update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-04-30T16:59:28.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A new site revision entry (v3.5.2) was added and an older revision (v3.5.0) was removed.
    Difference
    0.1%
    Check dated 2026-04-16T11:09:33.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:30:57.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added a new revision entry for v3.4.3 and removed the v3.4.2 entry from the version history.
    Difference
    0.1%
    Check dated 2026-03-11T20:07:15.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history. Removed the government-funding notice and the v3.4.1 entry from the history.
    Difference
    0.7%
    Check dated 2026-02-11T02:13:28.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Added a notice about a lapse in government funding and the NIH Clinical Center’s operating status with links to cc.nih.gov and opm.gov. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.7%
    Check dated 2026-02-04T00:47:18.000Z thumbnail image

Stay in the know with updates to CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page.